ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $3.80 billion. The enterprise value is $3.00 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 171.24 million shares outstanding. The number of shares has increased by 2.73% in one year.
| Current Share Class | 171.24M |
| Shares Outstanding | 171.24M |
| Shares Change (YoY) | +2.73% |
| Shares Change (QoQ) | +0.79% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 72.25% |
| Float | 127.35M |
Valuation Ratios
The trailing PE ratio is 10.10 and the forward PE ratio is 40.91.
| PE Ratio | 10.10 |
| Forward PE | 40.91 |
| PS Ratio | 3.47 |
| Forward PS | 3.87 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 3.33 |
| P/FCF Ratio | 33.44 |
| P/OCF Ratio | 30.75 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 32.33, with an EV/FCF ratio of 26.39.
| EV / Earnings | 7.98 |
| EV / Sales | 2.74 |
| EV / EBITDA | 32.33 |
| EV / EBIT | 37.05 |
| EV / FCF | 26.39 |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.59 |
| Quick Ratio | 3.27 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 0.45 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 37.32% and return on invested capital (ROIC) is 17.83%.
| Return on Equity (ROE) | 37.32% |
| Return on Assets (ROA) | 3.69% |
| Return on Invested Capital (ROIC) | 17.83% |
| Return on Capital Employed (ROCE) | 6.22% |
| Weighted Average Cost of Capital (WACC) | 8.86% |
| Revenue Per Employee | $1.37M |
| Profits Per Employee | $470,739 |
| Employee Count | 798 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 15.44 |
Taxes
| Income Tax | -260.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.60% in the last 52 weeks. The beta is 0.86, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +26.60% |
| 50-Day Moving Average | 21.87 |
| 200-Day Moving Average | 23.73 |
| Relative Strength Index (RSI) | 50.82 |
| Average Volume (20 Days) | 1,956,752 |
Short Selling Information
The latest short interest is 10.98 million, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 10.98M |
| Short Previous Month | 10.64M |
| Short % of Shares Out | 6.41% |
| Short % of Float | 8.62% |
| Short Ratio (days to cover) | 5.87 |
Income Statement
In the last 12 months, ACAD had revenue of $1.10 billion and earned $375.65 million in profits. Earnings per share was $2.20.
| Revenue | 1.10B |
| Gross Profit | 674.45M |
| Operating Income | 80.91M |
| Pretax Income | 115.11M |
| Net Income | 375.65M |
| EBITDA | 92.71M |
| EBIT | 80.91M |
| Earnings Per Share (EPS) | $2.20 |
Full Income StatementBalance Sheet
The company has $851.46 million in cash and $50.79 million in debt, with a net cash position of $800.66 million or $4.68 per share.
| Cash & Cash Equivalents | 851.46M |
| Total Debt | 50.79M |
| Net Cash | 800.66M |
| Net Cash Per Share | $4.68 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 7.29 |
| Working Capital | 790.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $123.49 million and capital expenditures -$9.90 million, giving a free cash flow of $113.59 million.
| Operating Cash Flow | 123.49M |
| Capital Expenditures | -9.90M |
| Depreciation & Amortization | 11.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 113.59M |
| FCF Per Share | $0.66 |
Full Cash Flow StatementMargins
Gross margin is 61.58%, with operating and profit margins of 7.39% and 34.30%.
| Gross Margin | 61.58% |
| Operating Margin | 7.39% |
| Pretax Margin | 10.51% |
| Profit Margin | 34.30% |
| EBITDA Margin | 8.46% |
| EBIT Margin | 7.39% |
| FCF Margin | 10.37% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.73% |
| Shareholder Yield | -2.73% |
| Earnings Yield | 9.89% |
| FCF Yield | 2.99% |
Analyst Forecast
The average price target for ACAD is $30.86, which is 39.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.86 |
| Price Target Difference | 39.13% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 8.79% |
| EPS Growth Forecast (5Y) | 10.58% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 6.24 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.24 |
| Piotroski F-Score | 5 |
